⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ICCM News
IceCure Medical Ltd. Ordinary Shares
IceCure Medical Receives Regulatory Approval to Market ProSense® in China
prnewswire.com
ICCM
IceCure Signs Exclusive Distribution Agreement for ProSense® Cryoablation Systems in the Netherlands
prnewswire.com
ICCM
West Cancer Center Receives IRB Approval to Commence IceCure's ChoICE Study for Breast Cancer Cryoablation
prnewswire.com
ICCM
IceCure Highlights Two New Peer-Reviewed Publications Supporting Cryoablation in Breast Cancer Treatment De-Escalation
prnewswire.com
ICCM
IceCure Reports its Financial Results for the First Half of 2026 with 45% Revenue Growth Year-Over-Year
prnewswire.com
ICCM
IceCure Medical Adds Adventist Health as U.S. Clinical Site for its Post-Marketing "ChoICE" Study for Low-Risk Breast Cancer Cryoablation Treatment
prnewswire.com
ICCM
IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance of ProSense®
prnewswire.com
ICCM
IceCure Medical Kicks Off its Post-Marketing "ChoICE" Study for the Low-Risk Breast Cancer Treatment at First U.S Clinical Site
prnewswire.com
ICCM
IceCure Expands U.S. Commercial Team to Meet Surging Demand for ProSense® Cryoablation
prnewswire.com
ICCM
IceCure Highlights Expanding Commercial Adoption of ProSense™ Cryoablation in Brazil Following FDA Clearance for Breast Cancer
prnewswire.com
ICCM